UEMS Medical Specialty

Oncology & FSMP

Oncology nutrition and Food for Special Medical Purposes (FSMP): glycolysis-restricted formulas, anti-tumour nutritional support, haematological support, and CDMO-grade medical food manufacturing.

7

dossiers

Cerebral Bioenergetics & Neuro-Metabolic Rescue

Food Supplements and Medical Foods in Brain Function: A Mechanism-Anchored Evidence Map

Formulators face significant challenges in developing evidence-based brain health supplements due to a lack of clear, mechanism-anchored frameworks for evaluating ingredient efficacy and quality of supporting human data across diverse brain function domains.

Dietary Supplements Medical Foods Brain Cognition

Cerebral Bioenergetics & Neuro-Metabolic Rescue

Glioblastoma: Epidemiology, Pathology, Molecular Biology, and Therapeutic Landscape

Developing effective glioblastoma therapies is hampered by the tumor's aggressive proliferation, profound intratumoral heterogeneity, and the inherent difficulty in delivering therapeutic agents across the blood-brain barrier to the highly immunosuppressive microenvironment.

Glioblastoma Brain Neoplasms Epidemiology Pathology, Molecular

Catecholamine Homeostasis & Executive Function

Psychological State and Cancer: Modulatory Roles in Progression and Outcomes

Developing targeted therapies that address the modulatory effects of chronic psychological stress and associated neuroendocrine pathways on tumor progression and patient outcomes in oncology remains a complex challenge.

Psychological Stress Neoplasms Disease Progression Hypothalamo-Hypophyseal System

Glycolysis-Restricted FSMP (Oncology Nutrition)

Technologies and Ingredients for Glycolysis-Restricted Medical Foods in Oncology Nutrition

Developing glycolysis-restricted Foods for Special Medical Purposes (FSMP) for oncology patients is challenged by cancer cachexia, patient dysgeusia, and the need for advanced solutions in lipid-based formulation and product stability.

Foods, Specialized Nutrition Therapy Neoplasms Cachexia

Intracellular Defense & IV-Alternatives

Personalized mRNA Neoantigen Vaccines: Efficacy and Safety in Melanoma and PDAC

Developing personalized mRNA neoantigen vaccines requires rapid, custom manufacturing workflows within a narrow therapeutic window, presenting significant logistical and scale-up complexities for widespread clinical adoption.

RNA, Messenger Vaccines, Synthetic Neoantigens Immunotherapy

Glycolysis-Restricted FSMP (Oncology Nutrition)

The Glucose Paradox in Oncology Nutrition: Metabolic Compatibility of Medical Foods

Formulating oncology-specific medical foods that balance caloric adequacy with metabolic compatibility is challenging, as standard high-glycemic carbohydrate profiles can inadvertently fuel tumor progression and worsen cachexia in vulnerable patients.

Insulin Resistance Neoplasms Medical Oncology Glycolysis

Cerebral Bioenergetics & Neuro-Metabolic Rescue

Ketogenic Diet-Specified Interventions in Neurodegenerative Disease Mechanisms

Developing a formulation that achieves consistent and measurable ketosis while optimizing bioavailability and tolerability in neurodegenerative conditions is a key challenge.

Alzheimer Disease Parkinson Disease Neurodegenerative Diseases Neuroinflammation

Custom Formulation Available

Need a Dossier Built Around Your Molecule?

Our R&D team will conduct a Paid Discovery Audit and build a proprietary clinical dossier for your specific active ingredient or therapeutic target. Full IP transfer included.